Keywords
COVID-19
Sub notification
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To verify the frequency of breast and prostate cancer during the COVID-19 pandemic. Methods: This is a described, retrospective and documentary study. The sample was patients with cancer in an oncology service at Caruaru-PE, registered between 2019 to 2022. Results: The comparison between 2019-2020 there was an 8,3% drop in the register of breast cancer and a 9% drop of prostate cancer. 2020-2021 there was a 12,1% increase of breast cancer and 10,4% increase of prostate cancer registered, considering that some months the services were coming back. And comparing 2021-2022 there was a 28,4% increase of breast cancer and 22,9% increase of prostate cancer. Thus, the results show a drop in the register of cancer during the period of higher restrictions of access to services Conclusion: From the data obtained was possible to evidence the impact of COVID-19 in the cancer register, leading to a possible sub notification of the cases in that period, then is necessary to available the impact survival of cancer patients in the next years.
References
ANDRADE CM, et al. Ações de Detecção Precoce do Câncer de Mama no Brasil: Análise dos Dados do Sistema de Informação do Controle do Câncer de Mama (Sismama), 2009-2015. Revista Brasileira de Cancerologia, 2022, 68(3): e082189.
ANAND KB, et al. SARS-CoV-2: Camazotz's Curse. Medical Journal Armed Forces India, 2020, 76: 136–141.
BRASIL. MINISTÉRIO DA SAÚDE. SECRETARIA DE ATENÇÃO PRIMÁRIA À SAÚDE. DEPARTAMENTO DE PROMOÇÃO DA SAÚDE. Estimativa 2023: Incidência de câncer no Brasil. Biblioteca virtual em saúde, 2022; 162p.
CAMPOS MDSB, et al. Os Benefícios dos Exercícios Físicos no Câncer de Mama. Arquivos Brasileiros de Cardiologia. 2022, 119(6): 981-990.
CARLSSON VS; VICKERS JA. Screening for prostate cancer. Medical Clinics of North America, 2020, 104(6): 1051-1062.
DE VINCENTIIS J, et al. Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathology. Journal of Clinical Pathology, 2021, 74( 3): 187-189.
DOURADO ORAC, et al. Câncer de mama e análise dos fatores relacionados aos métodos de detecção e estadiamento da doença. Revista Cogitare Enfermagem, 2022, 27: e81039.
DINMOHAMED GA, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. The Lancet Oncology, 2020, 21(6): 750-751.
FERREIRA SS, et al. Indications for breast magnetic resonance imaging at a referral center for diagnosis and treatment of breast cancer in Brazil. Radiologia Brasileira, 2021, 54(2): 83-86.
GARRIDO RG; RODRIGUES RC. Restrição de contato social e saúde mental na pandemia: possíveis impactos das condicionantes sociais. Journal of Health & Biological Siences, 2020, 8(1): 1-9.
JACOB L, et al. Impact of the COVID-19 pandemic on cancer in general and specialized practices in Germany. Cancers, 2021, 13(3): 408.
KAUFMAN WH, et al. Changes in the number of US patients with newly identified cancer before and during the Coronavirus disease (COVID-19) pandemic. JAMA Network Open, 2020, 3(8): e2017267.
NORA CR. Conflitos bioéticos sobre distanciamento social em tempos de pandemia. Revista Bioética, 2021, 29(1): 10-20.
OLIVEIRA GI, et al. impacto da pandemia da COVID-19 nos exames de rastreamento do câncer no Brasil: um estudo comparativo dos cânceres de mama, próstata e colo de útero. Jornal Brasileiro de Economia da Saúde, 2022, 14(3): 217-222.
OLIVEIRA ST; MAGALHÃES VN. Efeitos do uso de imunonutrientes no paciente com câncer. Revista Eletrônica Acervo Científico, 2023, 46: e14569.
PEREIRA KG, et al. Fatores associados à masculinidade no diagnóstico precoce do câncer de próstata: revisão narrativa. Nursing, 2021, 24(277): 5803-5818.
RIBEIRO CM; CORREA FM; MIGOWSKI A. Efeitos de curto prazo da pandemia de COVID-19 na realização de procedimentos de rastreamento, investigação diagnóstica e tratamento do câncer no Brasil: estudo descritivo, 2019-2020. Epidemiologia e Serviços de Saúde, 2022, 31(1): 53-60.
THENRAJAN T; ALWARAPPAN S; WILSON J. Molecular Diagnosis and Cancer Prognosis-A Concise Review. Diagnostics, 2023, 13(4): 766.
ZADNIK V, et al. Impact of COVID-19 on cancer diagnosis and management in Slovenia - Preliminary results. Radiology and Oncology, 2020, 54(3): 329-334.